Abbvie, Inc. (ABBV) Earnings
|
Expand Research on ABBV
| Next EPS Date | 7/24/26 | EPS Growth Rate | +26.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +2.4% | Revenue Growth Rate | +8.8% |
| Average % Move 1-Wk after EPS | +0.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/24/26  |
Q226 | N/A | $3.77 | N/A | N/A | $16.78B | = | N/A | N/A | ||
| 4/29/26 | Q126 | $2.65 | $2.59 | +$0.06 | $15B | $14.73B | = |  | | Details | |
| 2/4/26 | Q425 | $2.71 | $2.65 | +$0.06 | $16.62B | $16.39B | = | | | Details | |
| 10/31/25 | Q325 | $1.86 | $1.78 | +$0.08 | $15.78B | $15.58B | = | | | Details | |
| 7/31/25 | Q225 | $2.97 | $2.96 | +$0.01 | $15.42B | $14.99B | = | | | Details | |
| 4/25/25 | Q125 | $2.46 | $2.39 | +$0.07 | $13.34B | $12.93B | = | | | Details | |
| 1/31/25 | Q424 | $2.16 | $2.06 | +$0.10 | $15.1B | $14.82B | = | | | Details | |
| 10/30/24 | Q324 | $3.00 | $2.92 | +$0.08 | $14.46B | $14.28B | = | | | Details |
